🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
DMX-200 (repagermanium) is a C-C chemokine receptor type 2 (CCR2) inhibitor...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-05-30
Trial ID
NCT05183646
This study will be evaluating the safety and efficacy of propagermanium for...
Status
Completed
Location
Renal Research
Start Date
2018-11-08
Trial ID
NCT03649152
Treatments Being Tested
This study will be evaluating the safety and efficacy of propagermanium for...
Status
Completed
Location
Renal Research
Start Date
2018-11-06
Trial ID
NCT03627715
Treatments Being Tested
CLARITY 2.0 is an investigator-initiated trial that will evaluate the safet...
Status
Terminated
Location
Jawaharlal Nehru Medical College and Hospital
Start Date
2022-01-07
Trial ID
NCT05122182
Treatments Being Tested